Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk shares hit by concerns over rival diabetes drugs
Novo Nordisk shares hit by concerns over rival diabetes drugs
Novo Nordisk shares hit by concerns over rival diabetes drugs
Submitted by
admin
on June 17, 2013 - 9:17am
Source:
Reuters
News Tags:
diabetes
Novo Nordisk
Sanofi
Eli Lilly
dulaglutide
Victoza
Lyxumia
Lantus
Headline:
Novo Nordisk shares hit by concerns over rival diabetes drugs
Do Not Allow Advertisers to Use My Personal information
